Plasma fibrinogen in ulcerative colitis: The effect of disease activity and nicotine therapy in a randomised controlled trial

Digestive and Liver Disease

Volumn 37, Issue 11, 2005, Pages 832-837

  Ingram, J R ^a   Rhodes, J ^a   Collins, P W ^b   Williams, G T ^c   Newcombe, R G ^d   Thomas, G A O ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b Cardiff and Vale Trust HeartLink Project   (United Kingdom)

^c CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Fibrinogen; Nicotine enema; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; ENEMA; FIBRINOGEN; NICOTINE; PLACEBO; PREDNISOLONE; NICOTINIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; RECTUM BIOPSY; REFERENCE VALUE; SENSITIVITY ANALYSIS; SIGMOIDOSCOPY; ULCERATIVE COLITIS; BLOOD; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

COLITIS, ULCERATIVE; ENEMA; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY;

EID: 33644877074     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.05.010     Document Type: Article

References (23)

1. Belch J.J.F., McArdle B.M., Burns P., Lowe G.D.O., and Forbes C.D. The effects of acute smoking on platelet behaviour, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost 51 (1984) 6-8
2. Wilhelmsen L., Svardsudd K., Korsan-Bengtsen K., Larsson B., Welin L., and Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311 (1984) 501-505
3. Kannel W.B., Wolf P.A., Castelli W.P., and D'Agostino R.B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. J Am Med Assoc 258 (1987) 1183-1186
4. Haustein K.O., Krause J., Haustein H., Rasmussen T., and Cort N. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Intern Med 252 (2002) 130-139
5. Harries A.D., Baird A., and Rhodes J. Non smoking: a feature of ulcerative colitis. Br Med J 284 (1982) 706
6. Jick H., and Walker A.M. Cigarette smoking and ulcerative colitis. N Engl J Med 308 (1983) 261-263
7. Boyko E.J., Koepsell T.D., Perera D.R., and Inui T.S. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 316 (1987) 707-710
8. Calkins B.M. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34 (1989) 1841-1854
9. Rudra T., Motley R., and Rhodes J. Does smoking improve colitis?. Scand J Gastroenterol Suppl 170 (1989) 61-63
10. Thomas G.A., Davies S.V., Rhodes J., Russell M.A., Feyerabend C., and Sawe U. Is transdermal nicotine associated with cardiovascular risk?. J R Coll Physicians Lond 29 (1995) 392-396
11. Schultz D.R., and Arnold P.I. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum 20 (1990) 129-147
12. Green J.T., Rhodes J., Thomas G.A.O., Evan B.K., Feyerabend C., Russell M.A.H., et al. Nicotine carbomer enemas-pharmacokinetics of a revised formulation. Ital J Gastroenterol Hepatol 30 (1998) 260-265
13. Dick A.P., Grayson M.J., Carpenter R.G., and Petrie A. Controlled trial of sulphasalazine in the treatment of ulcerative colitis. Gut 5 (1964) 437-442
14. Sutherland L.R., Martin F., Greer S., Robinson M., Greenberger N., Sabil F., et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92 (1987) 1894-1898
15. Feyerabend C., and Russell MA.H. A rapid gas-liquid chromatographic method for the determination of nicotine and cotinine in biological fluids. J Pharm Pharmacol 42 (1990) 450-452
16. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17 (1957) 237-246
17. Gaffney P.J., and Wong M.T. Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thromb Haemost 68 (1992) 428-432
18. Lowe G.D.O., Rumley A., Woodward M., Morrison C.E., Philippou H., Lane D.A., et al. Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 97 (1997) 775-784
19. Van Bodegraven A.A., Schoorl M., Baak J.P., Linskens R.K., Bartels P.C., and Tuynman H.A. Hemostatic imbalance in active and quiescent ulcerative colitis. Am J Gastroenterol 96 (2001) 487-493
20. Van Bodegraven A.A., Schoorl M., Linskens R.K., Bartels P.C., and Tuynman H.A. Persistent activation of coagulation and fibrinolysis after treatment of active ulcerative colitis. Eur J Gastroenterol Hepatol 14 (2002) 413-418
21. Linskens R.K., van Bodegraven A.A., Schoorl M., Tuynman H.A., and Bartels P. Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci 46 (2001) 644-648
22. Kumar S., Ghoshal U.C., Aggarwal R., Saraswat V.A., and Choudhuri G. Severe ulcerative colitis: prospective study of parameters determining outcome. J Gastroenterol Hepatol 19 (2004) 1247-1252
23. Truelove S.C., and Richards WC.D. Biopsy studies in ulcerative colitis. Br Med J 1 (1956) 1315-1321